FGF21 and Pruritus: Pruritus incidence is dose-dependent and higher when OCA is used as monotherapy.53,54 HSP763-01 functions as a dual-target fusion protein of GLP-1 and FGF21 to prevent the common adverse reactions caused by OCA.